Tag: For

Elixir Medical’s 24-Month Clinical Results for DynamX Bioadaptor Showed Strong Safety Profile, With No Clinical Events

eTN Managing Editor eTN Managing Editor- January 28, 2021 09:28

The DynamX Bioadaptor is a new class of treatment for Coronary Artery Disease. SINGAPORE, January 28, 2021 /EINPresswire.com/ -- Elixir Medical’s 24-Month Clinical Results for DynamX Bioadaptor Showed Strong Safety ... Read More